In this non-tumoral fraction, the most frequent mutations involved the chromatin-remodeling genes CREBBP (16.67%) and SMARCA4 (16.67%), coherent with the central role of epigenetic modifications in the pathogenesis of refractory cHL. Here, CREBBP is linked to classic Hodgkin lymphoma.